BPI-9016M
Emibetuzumab
Rilotumumab
Ficlatuzumab
Onartuzumab
Narnatumab
(rel)-Tivantinib
Davutamig
c-Met-IN-18
Tepotinib
Dihexa
c-Met-IN-2
Ensartinib
c-Met-IN-1
Meleagrin
PF-04217903 phenolsulfonate
Norleual
MET kinase-IN-2
c-Met-IN-9
AC-386